On May 15, 2007, medical diagnostics company MonoGen, Inc. announced that it had closed a short form prospectus equity offering for aggregate proceeds of US$12.4 million, including proceeds received upon the exercise of the underwriters' over-allotment option. The syndicate of underwriters for this financing was led by GMP Securities L.P., and included Canaccord Capital Corporation and Paradigm Capital Inc. The underwriters were advised by Rubin Rapuch, Georges Dubé and Jeffrey Klam of Fasken Martineau.
